Tranxene T-tab
NDC Package 67386-302-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Tranxene T-tab is clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. Marketed by Lundbeck Llc, this product is identified by NDC 67386-302 and is authorized under FDA application NDA017105.

Identification & Billing

NDC Package Code
67386-302-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
67386-302
11-Digit Billing Format
67386030201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Tranxene T-tab
Dosage Form
-
Usage Information
Clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. This medication belongs to a class of drugs called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

Regulatory & Marketing

Labeler Name
Lundbeck Llc
FDA Application #
NDA017105
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-23-1972
End Marketing Date
04-12-2013
Listing Expiration
04-12-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67386-302-01 identifies a specific commercial package of 100 tablet in 1 bottle of Tranxene T-tab, labeled by Lundbeck Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Lundbeck Llc on June 23, 1972. The current certification is valid through April 12, 2013.

What are the primary indications for this medication?

Clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. This medication belongs to a class of drugs called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

How is this Lundbeck Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67386030201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67386-302-01
11-Digit CMS (5-4-2)
67386-0302-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.